“…From these, 17 variants (0.57±0.77, mean±SD) have varying probabilities of pathogenicity. These include variants in genes routinely screened with Sanger sequencing—that is, MYH7 : NM_000257.2: c.1178C>T,26–28 c.1231G>A,29–32 c.2002C>A, c.5135G>A, c.1987C>T, c.121G>A and MYBPC3 : NM_000256.3: c.2827C>T,33 c.3004C>T (twice), c.2864_2865del, MYL2 : NM_000432.3: c.37G>A34–37 and TPM1 : NM_000366.5: c.618A>G, but also in genes that are part of the additional genes in the NG cardiomyopathy panel—that is, SCN5A : NM_198056.2: c.3157G>A38 39, PRKAG2 : NM_016203.3: c.253C>T, TCAP : NM_003673.2: c.37_39del,40 41 CSRP3 : NM_003476.3: c.10T>C42 43, LMNA : NM_170707.2: c.1804G>A,44 45 DES : NM_001927.3: c.935A>C (table 4). Ten patients had a single variant, two patients had two variants each ( MYH7 : NM_000257.2: c.1178C>T combined with SCN5A : NM_198056.2: c.3157G>A, and MYBPC3 : NM_000256.3: c.3004C>T combined with LMNA : NM_170707.2: c.1804G>A), and one patient had three variants ( MYH7 : NM_000257.2: c.121G>A, MYBPC3 : NM_000256.3: c.3004C>T, and DES : NM_001927.3: c.935A>C).…”